Редактирование:
Aging genes 20-29
(раздел)
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
==LRRK2== * {{medline-title |title=Aberrant mitochondrial morphology and function associated with impaired mitophagy and [[DNM1L]]-MAPK/ERK signaling are found in aged mutant Parkinsonian [[LRRK2]] mice. |date=10.12.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33300446 |full-text-url=https://sci-hub.do/10.1080/15548627.2020.1850008 }} * {{medline-title |title=Accelerated telomere shortening independent of [[LRRK2]] variants in Chinese patients with Parkinson's disease. |date=29.10.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33122450 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655166 }} * {{medline-title |title=Attenuation of epigenetic regulator [[SMARCA4]] and ERK-ETS signaling suppresses aging-related dopaminergic degeneration. |date=09.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32749068 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511865 }} * {{medline-title |title=The effect of [[LRRK2]] loss-of-function variants in humans. |date=06.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32461697 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303015 }} * {{medline-title |title=Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging. |date=19.02.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32075681 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031993 }} * {{medline-title |title=Autophagy and [[LRRK2]] in the Aging Brain. |date=2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31920513 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928047 }} * {{medline-title |title=SerThr-PhosphoProteome of Brain from Aged [[PINK1]]-KO A53T-[[SNCA]] Mice Reveals pT1928-[[MAP1B]] and pS3781-[[ANK2]] Deficits, as Hub between Autophagy and Synapse Changes. |date=04.07.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31277379 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651490 }} * {{medline-title |title=Age-dependent accumulation of oligomeric [[SNCA]]/α-synuclein from impaired degradation in mutant [[LRRK2]] knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). |date=02.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30983487 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984454 }} * {{medline-title |title=A Neuron-Glial Trans-Signaling Cascade Mediates [[LRRK2]]-Induced Neurodegeneration. |date=12.02.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30759389 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474846 }} * {{medline-title |title=Upregulation of the p53-p21 pathway by G2019S [[LRRK2]] contributes to the cellular senescence and accumulation of α-synuclein. |date=02.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30712480 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422450 }} * {{medline-title |title=G2019S [[LRRK2]] mutation facilitates α-synuclein neuropathology in aged mice. |date=12.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30172844 |full-text-url=https://sci-hub.do/10.1016/j.nbd.2018.08.018 }} * {{medline-title |title=The Enzymatic Core of the Parkinson's Disease-Associated Protein [[LRRK2]] Impairs Mitochondrial Biogenesis in Aging Yeast. |date=2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29977190 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021522 }} * {{medline-title |title=Age-related pathology after adenoviral overexpression of the leucine-rich repeat kinase 2 in the mouse striatum. |date=06.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29550548 |full-text-url=https://sci-hub.do/10.1016/j.neurobiolaging.2018.02.008 }} * {{medline-title |title=[[LRRK2]] G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT Receptor Upregulation in Mice. |date=14.02.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29305532 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705874 }} * {{medline-title |title=Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice. |date=15.11.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29056298 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693787 }} * {{medline-title |title=Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in [[LRRK2]] G2019S knock-in mice. |date=20.09.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28930069 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633343 }} * {{medline-title |title=Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and [[LRRK2]] G2019S Parkinson's disease model mice challenged with lipopolysaccharide. |date=18.11.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28958936 |full-text-url=https://sci-hub.do/10.1016/j.bbrc.2017.09.129 }} * {{medline-title |title=Progression of pathology in [[PINK1]]-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation. |date=02.08.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28768533 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541666 }} * {{medline-title |title=Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S [[LRRK2]] mice. |date=14.03.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28292328 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351259 }} * {{medline-title |title=Combined [[LRRK2]] mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease. |date=18.01.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28098219 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241661 }} * {{medline-title |title=[[LRRK2]] BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function. |date=01.03.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26744332 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754049 }} * {{medline-title |title=Functional and Morphological Correlates in the Drosophila [[LRRK2]] loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration. |date=2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26727265 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699764 }} * {{medline-title |title=G2019S [[LRRK2]] and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. |date=12.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26253900 |full-text-url=https://sci-hub.do/10.1007/s00702-015-1438-9 }} * {{medline-title |title=An early axonopathy in a h[[LRRK2]](R1441G) transgenic model of Parkinson disease. |date=10.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26192625 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640977 }} * {{medline-title |title=Mutations in [[LRRK2]] potentiate age-related impairment of autophagic flux. |date=11.07.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26159606 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702340 }} * {{medline-title |title=[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat. |date=08.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25833342 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528008 }} * {{medline-title |title=Changes in actin dynamics and F-actin structure both in synaptoneurosomes of [[LRRK2]](R1441G) mutant mice and in primary human fibroblasts of [[LRRK2]](G2019S) mutation carriers. |date=22.01.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25301747 |full-text-url=https://sci-hub.do/10.1016/j.neuroscience.2014.09.070 }} * {{medline-title |title=Genetic and pharmacological evidence that G2019S [[LRRK2]] confers a hyperkinetic phenotype, resistant to motor decline associated with aging. |date=11.2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25107341 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194318 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup